LifeCell, an Acelity Company
Acelity is a global market leader in advanced wound therapeutics and regenerative medicine, offering innovative solutions from the hospital to home that improve the lives of patients in more than 80 countries. Their mission is to change the practice of medicine with solutions that speed healing, create economic value and improve patients’ lives.
The LifeCell Portfolio
LifeCell is focused on the development and commercialization of regenerative and reconstructive acellular tissue matrices for use in general and reconstructive surgical procedures to repair soft tissue defects, as well as autologous fat grafting solutions.
Single-use, sterile, disposable device intended for harvesting, filtering, and transferring of autologous adipose tissue. It can be used in large volume fat grafting procedures.
It delivers predictable results, is fast, efficient, and is easy to use.
CYMETRA(TM) MICRONIZED ALLODERM(TM) Tissue (MAT)
Micronized, particulate form of ALLODERM(TM) Tissue Matrix that contains the same key elements for tissue regeneration. CYMETRA(TM) MAT supports rapid revascularization, cell repopulation, and white cell migration.
Regenerative Tissue Matrix
Donated human dermis, processed to remove cells while preserving the essential biological components and structure of the dermal matrix to support regeneration.
STRATTICE(TM) Reconstructive Tissue Matrix
Intended for use as a soft tissue patch to reinforce soft tissue where weakness exists and for the surgical repair of damaged or ruptured soft tissue membranes.